Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncology|July 15, 2005
Plasma gelatinase activity does not reflect disease activity after operation for colorectal cancerE T Waas, Th Wobbes, R M L M Lomme, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 3, 2006
Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver diseaseE T Waas, Th Wobbes, T Ruers, et al.
British Journal of Cancer|June 27, 2002
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancerE T Waas, R M L M Lomme, J DeGroot, et al.
The British Journal of Surgery|December 4, 2003
Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasisE T Waas, T Wobbes, R M L M Lomme, et al.
International Journal of Colorectal Disease|February 27, 2004
Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgeryI H J T de Hingh, E T Waas, R M L M Lomme, et al.
The Journal of Investigative Dermatology|September 21, 2000
Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progressionU B Hofmann, J R Westphal, E T Waas, et al.
Molecular Genetics and Metabolism|June 2, 2001
Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?S G Heil, N M Van der Put, E T Waas, et al.
British Journal of Cancer|November 11, 1999
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progressionU B Hofmann, J R Westphal, E T Waas, et al.
Pageof 1